JDBRX
Price
$50.67
Change
+$0.11 (+0.22%)
Updated
Oct 8 closing price
Net Assets
27.56B
RLBBX
Price
$38.77
Change
+$0.17 (+0.44%)
Updated
Oct 8 closing price
Net Assets
266.1B
Interact to see
Advertisement

JDBRX vs RLBBX

Header iconJDBRX vs RLBBX Comparison
Open Charts JDBRX vs RLBBXBanner chart's image
Janus Henderson Balanced R
Price$50.67
Change+$0.11 (+0.22%)
VolumeN/A
Net Assets27.56B
American Funds American Balanced R2
Price$38.77
Change+$0.17 (+0.44%)
VolumeN/A
Net Assets266.1B
JDBRX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
JDBRX vs. RLBBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBRX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 266B vs. JDBRX (27.6B). JDBRX pays higher dividends than RLBBX: JDBRX (1.17) vs RLBBX (1.11). JDBRX was incepted earlier than RLBBX: JDBRX (16 years) vs RLBBX (23 years). RLBBX (1.32) and JDBRX (1.31) have similar cost to investors . JDBRX is a more actively managed with annual turnover of: 76.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than JDBRX: RLBBX (250) vs JDBRX (2500). RLBBX annual gain was more profitable for investors over the last year : 9.08 vs. JDBRX (8.12). RLBBX return over 5 years is better than : 38.13 vs. JDBRX (35.35).
JDBRXRLBBXJDBRX / RLBBX
Total Expense Ratio1.311.3299%
Annual Report Gross Expense Ratio1.311.3299%
Fund Existence16 years23 years-
Gain YTD12.84814.26290%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets27.6B266B10%
Annual Yield % from dividends1.171.11106%
Returns for 1 year8.129.0889%
Returns for 3 years46.4348.6195%
Returns for 5 years35.3538.1393%
Returns for 10 years89.6369.43129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.510.11
+7.86%
Pacific Biosciences of California
PCOR74.443.03
+4.24%
Procore Technologies
VANI1.380.01
+0.73%
Vivani Medical
HAO1.29N/A
N/A
Haoxi Health Technology Limited
AVDX9.95N/A
N/A
AvidXchange Holdings